Loading clinical trials...
Loading clinical trials...
B3 for NMD: Bench to Bedside and Back - Transformative Discoveries Leading to Improved Care in Neuromuscular Disease
Conditions
Interventions
B3 for NMD: Bench to Bedside and Back
Locations
1
Canada
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Start Date
May 6, 2019
Primary Completion Date
December 31, 2031
Completion Date
December 31, 2033
Last Updated
December 30, 2025
NCT06672237
NCT06084026
NCT07357428
NCT07021638
NCT07136844
NCT06573866
Lead Sponsor
Ottawa Hospital Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions